Additionally, TBX4 contributes to tumorigenesis in cancers such as pancreatic, lung, and bladder cancers, where recent studies suggest DNA methylation as a primary mechanism underlying TBX4 suppression, positioning it as a promising prognostic marker. This evidence concerns the gene TBX4 and urinary bladder carcinoma.